Related Experiment Video

Updated: Aug 24, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

COPD: is there light at the end of the tunnel?

Peter J Barnes1

  • 1National Heart and Lung Institute, Imperial College School of Medicine, Dovehouse St, London SW3 6LY, UK. p.j.barnes@imperial.ac.uk

Current Opinion in Pharmacology
|May 14, 2004
PubMed

Insights

New treatments targeting inflammation and cell influx are in development for chronic obstructive pulmonary disease (COPD). Research focuses on novel therapies and biomarkers to combat this progressive lung disease.

Area of Science:

  • Pulmonary Medicine
  • Inflammation Research
  • Pharmacology

Background:

  • Chronic obstructive pulmonary disease (COPD) lacks treatments that halt disease progression or inflammation.
  • Understanding COPD's inflammatory and destructive pathways has revealed new therapeutic targets.

Purpose of the Study:

  • To review emerging therapeutic strategies for COPD.
  • To highlight the need for biomarkers in clinical trials for new COPD treatments.

Main Methods:

  • Review of current clinical development pipelines for COPD therapies.
  • Analysis of targeted anti-inflammatory approaches.

Main Results:

  • Several novel therapies targeting inflammatory cell influx are in clinical development.
  • Broad-spectrum anti-inflammatory agents, including PDE4, p38 MAPK, and NF-κB inhibitors, are under investigation.
  • Targeted therapies include those against adhesion molecules and tumor necrosis factor-alpha.

Conclusions:

  • New therapeutic avenues are emerging for COPD management.
  • Validated biomarkers and monitoring techniques are crucial for advancing early clinical studies of novel COPD therapies.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: